Index
1 Biological Drugs Market Overview
1.1 Product Overview and Scope of Biological Drugs
1.2 Biological Drugs Segment by Type
1.2.1 Global Biological Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Therapeutic Protein
1.2.3 Monoclonal Antibody
1.2.4 Vaccine
1.2.5 Others
1.3 Biological Drugs Segment by Application
1.3.1 Global Biological Drugs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Biological Drugs Market Size Estimates and Forecasts
1.4.1 Global Biological Drugs Revenue 2019-2030
1.4.2 Global Biological Drugs Sales 2019-2030
1.4.3 Global Biological Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biological Drugs Market Competition by Manufacturers
2.1 Global Biological Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biological Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biological Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Biological Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biological Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biological Drugs, Product Type & Application
2.7 Biological Drugs Market Competitive Situation and Trends
2.7.1 Biological Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biological Drugs Players Market Share by Revenue
2.7.3 Global Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biological Drugs Retrospective Market Scenario by Region
3.1 Global Biological Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biological Drugs Global Biological Drugs Sales by Region: 2019-2030
3.2.1 Global Biological Drugs Sales by Region: 2019-2024
3.2.2 Global Biological Drugs Sales by Region: 2025-2030
3.3 Global Biological Drugs Global Biological Drugs Revenue by Region: 2019-2030
3.3.1 Global Biological Drugs Revenue by Region: 2019-2024
3.3.2 Global Biological Drugs Revenue by Region: 2025-2030
3.4 North America Biological Drugs Market Facts & Figures by Country
3.4.1 North America Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biological Drugs Sales by Country (2019-2030)
3.4.3 North America Biological Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biological Drugs Market Facts & Figures by Country
3.5.1 Europe Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biological Drugs Sales by Country (2019-2030)
3.5.3 Europe Biological Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biological Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biological Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Biological Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biological Drugs Market Facts & Figures by Country
3.7.1 Latin America Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biological Drugs Sales by Country (2019-2030)
3.7.3 Latin America Biological Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biological Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Biological Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biological Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biological Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Biological Drugs Sales by Type (2019-2030)
4.1.1 Global Biological Drugs Sales by Type (2019-2024)
4.1.2 Global Biological Drugs Sales by Type (2025-2030)
4.1.3 Global Biological Drugs Sales Market Share by Type (2019-2030)
4.2 Global Biological Drugs Revenue by Type (2019-2030)
4.2.1 Global Biological Drugs Revenue by Type (2019-2024)
4.2.2 Global Biological Drugs Revenue by Type (2025-2030)
4.2.3 Global Biological Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Biological Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biological Drugs Sales by Application (2019-2030)
5.1.1 Global Biological Drugs Sales by Application (2019-2024)
5.1.2 Global Biological Drugs Sales by Application (2025-2030)
5.1.3 Global Biological Drugs Sales Market Share by Application (2019-2030)
5.2 Global Biological Drugs Revenue by Application (2019-2030)
5.2.1 Global Biological Drugs Revenue by Application (2019-2024)
5.2.2 Global Biological Drugs Revenue by Application (2025-2030)
5.2.3 Global Biological Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Biological Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Myers Squibb Biological Drugs Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Biological Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Biological Drugs Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Biological Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Amgen Biological Drugs Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 F. Hoffmann-La Roche
6.6.1 F. Hoffmann-La Roche Corporation Information
6.6.2 F. Hoffmann-La Roche Description and Business Overview
6.6.3 F. Hoffmann-La Roche Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 F. Hoffmann-La Roche Biological Drugs Product Portfolio
6.6.5 F. Hoffmann-La Roche Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Biological Drugs Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck Biological Drugs Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Abbott Laboratories
6.9.1 Abbott Laboratories Corporation Information
6.9.2 Abbott Laboratories Description and Business Overview
6.9.3 Abbott Laboratories Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Abbott Laboratories Biological Drugs Product Portfolio
6.9.5 Abbott Laboratories Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Corporation Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Baxter Biological Drugs Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Biological Drugs Description and Business Overview
6.11.3 Novartis Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Novartis Biological Drugs Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Biological Drugs Description and Business Overview
6.12.3 Biogen Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Biogen Biological Drugs Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 GlaxoSmithKline
6.13.1 GlaxoSmithKline Corporation Information
6.13.2 GlaxoSmithKline Biological Drugs Description and Business Overview
6.13.3 GlaxoSmithKline Biological Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 GlaxoSmithKline Biological Drugs Product Portfolio
6.13.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biological Drugs Industry Chain Analysis
7.2 Biological Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biological Drugs Production Mode & Process
7.4 Biological Drugs Sales and Marketing
7.4.1 Biological Drugs Sales Channels
7.4.2 Biological Drugs Distributors
7.5 Biological Drugs Customers
8 Biological Drugs Market Dynamics
8.1 Biological Drugs Industry Trends
8.2 Biological Drugs Market Drivers
8.3 Biological Drugs Market Challenges
8.4 Biological Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer